CARDIOVASCULAR DISEASE RISK FACTOR

Clinical trials for CARDIOVASCULAR DISEASE RISK FACTOR explained in plain language.

Never miss a new study

Get alerted when new CARDIOVASCULAR DISEASE RISK FACTOR trials appear

Sign up with your email to follow new studies for CARDIOVASCULAR DISEASE RISK FACTOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 4 Not yet recruiting 1 Completed 2

Weight loss revolution: noom teams up with GLP-1 drugs in massive new study

Disease control Not yet recruiting

This study will test if combining GLP-1 medications (like semaglutide and tirzepatide) with Noom's digital health program helps people with obesity lose weight and improve health markers like blood sugar and cholesterol. About 2,310 adults will be followed for 24 months. The goal…

Matched conditions: CARDIOVASCULAR DISEASE RISK FACTOR

Sponsor: Noom Inc. • Aim: Disease control

Last updated May 26, 2026 09:25 UTC

CARDIOVASCULAR DISEASE RISK FACTOR

Get alerted when new CARDIOVASCULAR DISEASE RISK FACTOR trials appear

Weight loss revolution: noom teams up with GLP-1 drugs in massive new study